Stay updated on ACE-083 in Charcot-Marie-Tooth Disease Clinical Trial
Sign up to get notified when there's something new on the ACE-083 in Charcot-Marie-Tooth Disease Clinical Trial page.

Latest updates to the ACE-083 in Charcot-Marie-Tooth Disease Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.4.3 has been added. Revision: v3.4.2 has been removed.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedNo substantive content changes detected between the screenshots; observed differences appear to be cosmetic or formatting-related.SummaryDifference0.1%

- Check27 days agoChange DetectedScreenshots show the same study page with only minor visual/layout adjustments and no changes to core content such as study status, enrollment, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check34 days agoChange DetectedRevision updated to v3.4.2 and the prior v3.4.1 notice about government funding, operating status, and related updates was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedUpdates include a site-wide notice about governmental funding and the addition of a revision note (v3.4.1), which do not alter the study details or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedThe page now shows a glossary toggle, a 'Last Update Submitted that Met QC Criteria' indicator, and a 'No FEAR Act Data' notice, with the revision updated to v3.4.0. The previous items—'Last Update submitted that met QC Criteria' (lowercase), 'No FEAR Act data', and v3.3.4—were removed.SummaryDifference0.3%

Stay in the know with updates to ACE-083 in Charcot-Marie-Tooth Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACE-083 in Charcot-Marie-Tooth Disease Clinical Trial page.